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Abstract 
 
Objective 
To analyse if the association between depressive symptoms and hyperglycaemia is 
mediated by diabetes self-management. 
 
Methods 
430 people with diabetes (57.7% type 1, 42.3% type 2) were cross-sectionally 
assessed using validated self-report scales for depressive symptoms (Center for 
Epidemiologic Studies Depression Scale (CES-D)) and diabetes self-management 
(Diabetes Self-Management Questionnaire (DSMQ)); HbA1c was analysed 
simultaneously in a central laboratory. Structural equation modelling was used to test 
if the association between depressive symptoms and hyperglycaemia (HbA1c) was 
mediated by suboptimal self-management in people with type 1 and type 2 diabetes. 
 
Results 
The hypothesised model of depressive symptoms, diabetes self-management and 
hyperglycaemia fit the data well for both diabetes types (SRMR ≤ 0.04, TLI ≥ 0.99, 
CFI > 0.99, RMSEA ≤ 0.02 for both models). In both the type 1 and type 2 diabetes 
group, higher depressive symptoms were associated with lower self-management (P 
< 0.001), and lower self-management was associated with higher HbA1c (P < 0.001). 
Results indicated that the association between depressive symptoms and 
hyperglycaemia was significantly mediated by suboptimal diabetes self-management 
in both type 1 and type 2 diabetes patients (P < 0.001). Significant direct associations 
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between depressive symptoms and hyperglycaemia, not mediated by self-
management, could not be observed. 
 
Conclusions 
This study provides good evidence supporting that depression is linked to 
hyperglycaemia via suboptimal diabetes self-management in both major diabetes 
types. 
 
Keywords 
Depressive symptoms; mood disorder; HbA1c; hyperglycaemia; diabetes self-care; 
mediation
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Introduction 
Depression is a frequent comorbid condition in people with diabetes of both 
major diabetes types. According to evidence from three epidemiologic meta-
analyses, it is likely that about 11 to 12% of all people with diabetes meet the criteria 
for a major depressive disorder and another 10 to 20% are affected by minor forms of 
depression [1–3]. 
Depression is considered to be an adverse condition in people with diabetes 
because of evidence supporting significantly elevated risks of developing long-term 
complications of diabetes [4–6] as well as significantly increased cardiovascular and 
all-cause mortality [7,8]. Furthermore, a meta-analysis by Gonzalez et al. [9] based 
on 47 studies and over 17,000 subjects showed depression to be associated with 
significantly reduced diabetes treatment adherence. Certainly, the estimated mean 
correlations between depression and non-adherence of 0.18 for diet, 0.14 for 
medication intake, 0.14 for exercise, 0.10 for glucose monitoring and 0.21 for 
composite measures indicate rather small effects. Nevertheless, they confirm 
increased risks of poorer self-management behaviours in people with diabetes and 
comorbid depression. 
Depression in diabetes has also been associated with impaired glycaemic 
control. A meta-analysis by Lustman et al. [10], based on 24 studies and about 2,800 
subjects, estimated a mean correlation between depression and hyperglycaemia of 
0.17; type-specific values were 0.19 for type 2 and 0.16 for type 1 diabetes. 
Furthermore, a longitudinal study including over 11,000 people with type 2 diabetes 
showed that depression predicted consistently worse glycaemic control over a time 
span of 9 years [11]. These as well as other findings support an association between 
comorbid depression and hyperglycaemia. 
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Theoretically, depression, self-management and glycaemic control have been 
linked in that depression might lead to hyperglycaemia through suboptimal diabetes 
self-management [12]. This assumption is usually called the behavioural hypothesis 
of depression-related hyperglycaemia (as opposed to a biological one, focussing on 
stress-induced endocrine and inflammatory reactions). However, few studies have 
actually sought to test the hypothesis (which requires employing a mediational 
approach), and, even more importantly, those few ones which did yielded only little 
insight into the mechanisms mediating depression into hyperglycaemia [13–17]. 
Lustman et al. [13] assessed 188 people with type 1 diabetes for depression 
using the Symptom Checklist-90 and for diabetes self-management using the 
Summary of Diabetes Self-Care Activities Measure; HbA1c was estimated 
simultaneously. Their cross-sectional study demonstrated depressive symptoms to 
be significantly correlated with both lower self-management (r = –0.26, P < 0.001) 
and higher HbA1c (r = 0.23, P < 0.01). However, evidence supporting that the 
association between depression and HbA1c was indeed mediated by impaired self-
management was not found. Instead, the authors concluded that „other pathways 
[besides behaviour] should be investigated‟. 
Egede et al. [14] analysed the putative mediation using structural equation 
modelling and cross-sectional data from 126 people with type 2 diabetes. Depressive 
symptoms were assessed using the Patient Health Questionnaire-9, diabetes self-
management behaviours using the Summary of Diabetes Self-Care Activities 
Measure and HbA1c values were gained from contemporary medical records. The 
results confirmed a negative association between depressive symptoms and 
diabetes self-management (β = −0.28, P = 0.004). However, a significant association 
between diabetes self-management and HbA1c was not observed. Correspondingly, a 
mediating role for self-management could not be supported. 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
5 
 
A study by Dirmaier et al. [15] analysed the associations between depression, 
self-management and HbA1c in a prospective design with measurement time points at 
baseline and 12-month follow up. A population-based sample of 866 people with type 
2 diabetes was assessed using the Depression Screening Questionnaire; adherence 
to medication and diabetes-related health behaviours (diet, physical activity and 
smoking) were measured using Likert type questions; HbA1c values were reported by 
the treating physicians. The study once more supported significant associations 
between depression and both suboptimal self-management and impaired glycaemic 
control. However, neither cross-sectional nor prospective analyses supported the 
supposed mediating role for self-management. 
Chiu et al. [16] analysed associations between depressive symptoms, health 
behaviours and HbA1c using a structural equation modelling approach and 
prospective data from 998 patients with type 2 diabetes. At baseline, depressive 
symptoms were measured using the Center for Epidemiological Studies Depression 
Scale. At 2-year follow up, a composite measure of health behaviours was 
established (based on questions regarding physical exercise and smoking status as 
well as patients‟ BMI, which was used to rate their weight control behaviour). At 5-
year follow up, HbA1c was self-reported. The study was able to demonstrate a small 
but significant association between depressive symptoms at baseline and poorer 
health behaviour at 2-year follow up (β = –0.09, P < 0.001). Poorer health behaviour 
at 2-year follow up in turn predicted higher HbA1c at 5-year follow up (β = –0.17, P < 
0.001). However, the mediated effect of depressive symptoms on HbA1c came to no 
more than β = 0.015, explaining roughly 0.02% of glycaemic variation. 
Finally, McGrady et al. [17] analysed the putative mediation using cross-sectional 
data from 276 adolescents with type 1 diabetes. Variables were depressive 
symptoms (Children‟s Depression Inventory), glucose monitoring frequency (gained 
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from meters or by self-report) and HbA1c (estimated in one laboratory). The study 
found depressive symptoms significantly associated with a lower monitoring 
frequency (P = 0.02) and marginally significantly associated with higher HbA1c (P = 
0.05). When depressive symptoms and monitoring frequency were included into a 
single regression model of HbA1c, only monitoring was a significant statistical 
predictor (P < 0.001) while depressive symptoms was not (P = 0.19). A Sobel test 
supported the mediating role for glucose monitoring with P = 0.05. 
Although this last study provides some interesting results, there are several 
limitations: First, since standardised coefficients were not provided, the size of the 
effect is unclear. Second, since only a single behaviour rather than overall diabetes 
self-management was analysed, the inferability for self-management is limited. Third, 
since separate regression analyses were used without Bonferroni correction, the risk 
of type I error is increased. The last point is particularly important since the mediation 
only bordered on significance. 
To sum up the present evidence, not a single study has provided satisfactory 
evidence for the behavioural hypothesis of depression-related hyperglycaemia, and 
there is currently little evidence supporting that the association between depression 
and poor glycaemic control is mediated by impaired diabetes self-management. 
For this reason, we conducted the present study using data from a convenience 
sample of people with type 1 and type 2 diabetes. We aimed to analyse the direct 
and indirect (i. e. mediated) associations between depressive symptoms and 
glycaemic control using structural equation modelling (which has the advantage of 
testing the significance of all associations within one model; hence, type I error 
probability does not increase). To account for differences between the two diabetes 
types, the analyses were conducted separately for these groups. We hypothesised to 
find I) significant negative associations between depressive symptoms and diabetes 
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self-management, II) significant negative associations between self-management and 
HbA1c (meaning that better self-management is associated with better glycaemic 
control) and III) significant mediation effects between depressive symptoms and 
HbA1c via self-management. 
 
Materials and methods 
Data acquisition was performed as part of a larger study focussing affective 
symptoms in diabetes (identifier NCT01812291), approved by the Ethics Committee 
of the State Medical Chamber of Baden-Wuerttemberg. All data were collected from 
patients at a German in-patient diabetes centre (Diabetes Center Mergentheim), 
yielding a convenience sample of people with type 1 and type 2 diabetes. Inclusion 
criteria were: diabetes mellitus type 1 or 2 (diagnosis confirmed at the centre); age ≥ 
18 years; sufficient German language skills; written informed consent. 58% of the 
sample were enrolled into a clinical trial, for which elevated affective symptoms 
(CES-D score ≥ 16 and/or PAID score ≥ 40) were an additional inclusion criterion. 
Exclusion criteria were: terminal illness; being bedbound; being under guardianship. 
Eligible persons were approached at the centre and informed about the study. Those 
who consented to participate (62%) were assessed using validated self-report scales 
for depression (Center for Epidemiologic Studies Depression Scale) and diabetes 
self-management (Diabetes Self-Management Questionnaire), and provided venous 
blood for HbA1c analysis in a central laboratory. Demographic data were collected by 
nurses. Long-term complications were diagnosed by the centre‟s physicians. The 
study was carried out in accordance with the Declaration of Helsinki. All participants 
were informed about the study procedures and aims and provided written informed 
consent prior to enrolment. 
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Variables and measures 
Depressive symptoms 
Depressive symptoms were measured using the Center for Epidemiologic 
Studies Depression Scale (CES-D) [18]. The CES-D assesses the frequencies of 20 
common symptoms of depression during the previous week. Responses are given on 
a four-point Likert scale ranging from 0 – „rarely or never‟ to 3 – „most of the time‟. 
Total scores range between 0 and 60, with higher values indicating more depressive 
symptoms. The CES-D has very good reliability and validity in assessing depression 
[18,19], which was also confirmed for people with diabetes [20]. In the present study, 
Cronbach‟s α amounted to 0.88., indicating adequate reliability. 
 
Diabetes self-management 
Diabetes self-management was assessed using the Diabetes Self-Management 
Questionnaire (DSMQ) [21]. The scale consists of 16 items assessing behaviours 
related to the self-management of the condition. Respondents rate the extent to 
which each item applies to them on a four-point Likert scale (3 – „applies to me very 
much‟ to 0 – „does not apply to me‟), referring to the previous eight weeks. Item 
scores are summed and transformed to five scale scores with ranges from 0 to 10 
and higher scores indicating better behaviour. The scales reflect people with 
diabetes‟s „dietary control‟ (3 items), „medication adherence‟ (2 items), „blood glucose 
monitoring‟ (3 items), „physical activity‟ (3 items) and „physician contact‟ (3 items). 
The DSMQ has good reliability and validity [21–23]. In the present study, Cronbach‟s 
coefficients α were 0.79, 0.75, 0.83, 0.74 and 0.72 (scales in above order). 
 
Glycaemic control 
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To estimate glycaemic control, glycated haemoglobin (HbA1c) was assessed. All 
blood samples were analysed in one central laboratory at the same time as the 
psychometric assessments were conducted. HbA1c values were determined using 
high performance liquid chromatography, performed with the Bio-Rad Variant II 
Turbo analyser (meeting the current standards of HbA1c measurement; DCCT 
standard). The laboratory normal range is 4.3 – 6.1% (24 – 43 mmol/mol). 
 
Statistical Analyses 
The statistical analyses were performed using SPSS 22.0.0 including AMOS 
22.0.0 (IBM SPSS Statistics, New York, USA). Structural equation modelling was 
performed using maximum likelihood estimation. The hypothesised model was based 
on previous works in the field [14,16,22,24] and included the variables depressive 
symptoms, diabetes self-management and HbA1c (see Figure 1). To enable the 
analysis of diabetes self-management as a composite measure, it was modelled as 
latent variable operationalised by the DSMQ‟s five behaviour scales. This type of 
modelling was effectively employed in previous studies [14,22,24], and a recent study 
showed that self-management as assessed by the DSMQ can be modelled with good 
fit to the data using this approach [22]. 
The hypothesised model was then tested separately on the subsamples with type 
1 and type 2 diabetes (to account for the differences between these conditions, e.g. 
different relevancies of specific behaviours such as diet or exercise). Following 
relevant modification indices (threshold = 4.0), we successively modelled significant 
correlations between the variables‟ error terms. Model fit was evaluated based on the 
criteria suggested by Hu and Bentler [25]: Standardised Root Mean Square Residual 
(SRMR) ≤ 0.08, Tucker Lewis Index (TLI) ≥ 0.95, Comparative Fit Index (CFI) ≥ 0.95 
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and Root Mean Square Error of Approximation (RMSEA) ≤ 0.06 (90% CI upper 
bound ≤ 0.08). 
Associations between the independent and dependent model variables were 
assessed in the form of standardised regression coefficients (β). Levels of explained 
variation (i. e. statistical variance) in the dependent variables were estimated as 
squared multiple correlations (R2). Effect size appraisal for these outcomes can be 
made according to the established standards by Cohen [26]. 
The size of the hypothesised mediation effect was evaluated based on the 
appraisal criteria by Kenny [27], considering an indirect effect of β = 0.01 as small, β 
= 0.09 as medium and β = 0.25 as large (these values represent squared correlations 
of small, medium and large size according to the Cohen standards [26], referring to 
the fact that an indirect effect is the product of two single effects, which decreases its 
size). To test the hypothesised mediation effect for statistical significance using 
AMOS, boot strapping was applied using 5000 bootstrap samples. 
To account for potential confounding by socio-demographic variables, the tested 
models were fully adjusted for gender, age, BMI and education by modelling 
associations between these covariates and the three main variables, depressive 
symptoms, diabetes self-management and HbA1c. 
Since testing the hypothesised associations for both major types of diabetes 
separately required the use of two distinct model tests, leading to increased risk of a 
type I error, the p value was adjusted using the Bonferroni method as follows: P = 
0.05 / 2 = 0.025. Accordingly, a P value < 0.025 was used as criterion of statistical 
significance. 
Data exploration revealed non-normal distributions of three of the DSMQ scales 
(medication adherence, blood glucose monitoring and physician contact) as well as 
the CES-D. To warrant adequate normality, these variables were converted using 
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Templeton‟s two-step transformation, involving percentile ranking (first step; resulting 
in uniformly distributed probabilities) followed by applying the inverse-normal 
transformation (second step; yielding normally distributed z-scores) [28]. 
 
Results 
Characteristics of the study sample 
The sample comprised 430 people with diabetes; 248 were diagnosed with type 
1 diabetes (58%) and 182 with type 2 diabetes (42%). The sample characteristics are 
displayed in Table 1. 
People with type 1 diabetes were on average 39 years old and had a mean BMI 
of 27 kg/m2. With a prevalence of 60%, females were slightly overrepresented. The 
average diabetes duration amounted to approximately 17 years. Glycaemic control 
was clearly improvable as 71% of the patients had HbA1c values above 7.5% (60 
mmol/mol), the standard for acceptable control of the German Diabetes Association. 
31% of the patients were diagnosed with one or more long-term complications. 
People with type 2 diabetes had a mean age of 57 years and a mean BMI of 34 
kg/m2. With a rate of 46% of the sample being female, the gender distribution was 
relatively balanced. The majority (80%) was treated with insulin, corresponding to the 
rather long diabetes duration of 14 years. Glycaemic control was comparable to that 
of the type 1 diabetes group; approximately 73% had HbA1c values above 7.5% (60 
mmol/mol). Long-term complications were present in 62% of the patients. 
Study participants were generally comparable to typical clinic population, as 
there were no significant differences regarding gender, age, diabetes types, illness 
duration, glycaemic control and long-term complications. However, since part of the 
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sample was selected for elevated affective symptoms specifically, the sample‟s mean 
CES-D score was significantly higher (22 ± 11 vs. 17 ± 12). 
 
- Table 1 here - 
 
Structural equation model of depression-related hyperglycaemia for people 
with type 1 diabetes 
The structural equation model for people with type 1 diabetes is displayed in 
Figure 1. The model showed very good fit to the data, as indicated by the following fit 
indices: SRMR = 0.04; TLI = 0.99; CFI > 0.99; RMSEA = 0.02 (90% CI < 0.001 – 
0.06). The variable diabetes self-management was significantly operationalised by 
the assessed self-management behaviours (all path coefficients P < 0.001). Based 
on the related path coefficients (i. e. standardized regression coefficients), the most 
relevant behaviours were medication adherence, blood glucose monitoring and 
dietary control (see Figure 1). 
Higher depressive symptoms were significantly related to lower diabetes self-
management, explaining 6.3% of self-management variation, and lower diabetes self-
management was significantly related to hyperglycaemia (i. e. higher HbA1c), 
explaining 28% of variation in HbA1c (both P < 0.001). The bootstrapping test 
confirmed a significant indirect association between depressive symptoms and 
hyperglycaemia mediated by lower diabetes self-management (P < 0.001). The size 
of this indirect association amounted to β = 0.13 – medium to large according to 
Kenny [27] – indicating that an increase of depressive symptoms by 1 standard 
deviation (approx. 10 points on the CES-D) was associated with an increase of HbA1c 
by 0.13 of a standard deviation (i. e. 0.21 % points or 2.3 mmol/mol). While 
controlling for this indirect link between depressive symptoms and HbA1c in the 
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model, a significant concomitant direct association between depressive symptoms 
and HbA1c could not be observed (P = 0.13). 
 
- Figure 1 here - 
 
Structural equation model of depression-related hyperglycaemia for people 
with type 2 diabetes 
The model for type 2 diabetes is displayed in Figure 2. The results were 
generally comparable to those for the type 1 diabetes group: The model fit the data 
quite well (SRMR = 0.03; TLI > 0.99; CFI > 0.99; RMSEA < 0.001 [90% CI < 0.001 – 
0.03]); diabetes self-management was significantly operationalised by all assessed 
behaviours (all path coefficients P < 0.001); and the hypothesised associations 
between depressive symptoms, self-management and HbA1c were supported. Again, 
higher depressive symptoms were significantly related to lower diabetes self-
management, explaining 16.6% of variation in self-management, and lower self-
management was significantly related to hyperglycaemia, explaining 28.1% of 
variation in HbA1c (both P < 0.001). 
As hypothesised, higher depressive symptoms were indirectly linked to 
hyperglycaemia (i. e. higher HbA1c) via lower diabetes self-management, and the 
bootstrapping test confirmed this association as significant (P < 0.001). The revealed 
indirect effect of β = 0.22 – large according to Kenny [27] – indicated that an increase 
of depressive symptoms by 1 standard deviation (approx. 10 CES-D points) was 
associated with an increase of HbA1c by 0.22 standard deviations (i. e. 0.36 % points 
or 3.9 mmol/mol). Again, while controlling for the indirect path, a significant direct 
association between depressive symptoms and HbA1c could not be observed (P = 
0.24). 
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Notably, the type 2 diabetes model suggested a higher association between 
depressive symptoms and diabetes self-management compared to type 1 diabetes. 
However, testing this potential difference using multi-group analysis suggested no 
significant difference across groups (P = 0.32). 
 
- Figure 2 here - 
 
Discussion 
This study provides evidence supporting that depression relates to 
hyperglycaemia based on an indirect relationship via suboptimal diabetes self-
management. While the small number of previous studies which addressed this 
aspect found either no [13–15] or very little [16,17] support for a behavioural 
mediation between depression and poor glycaemic control, the results of our study 
are clearly in favour of the behavioural hypothesis of depression-related 
hyperglycaemia. In fact, the indirect associations observed here had moderate to 
large sizes, and could thus be uncovered with high significance using samples of 
relatively limited size. 
The lack of supportive evidence from previous studies is striking and needs to be 
discussed. We suppose that a reason for this might be suspected in the 
operationalisation of the variable self-management and potential limitations of the 
used measurement instruments. Lustman et al. as well as Egede et al. [13,14] 
utilised the Summary of Diabetes Self-Care Activities Measure, which was found to 
explain relatively little variation in glycaemic outcomes in several studies [21,22,29]. 
The analyses by Dirmaier et al. and Chiu et al. [15,16] were both based on self-
management aspects assessed using single questions which had not been rigorously 
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psychometrically tested. Furthermore, the behaviours analysed in these studies 
included smoking, alcohol consumption and physical activity which may not be 
regarded to directly affect blood glucose. In comparison, our study used the DSMQ, a 
validated psychometric tool which was supported as significant statistical predictor of 
glycaemic control, thus being more suitable for mediation analysis. 
In this study, we analysed depression as a metric variable (i. e. depressive 
symptoms) rather than diagnostic category. Therefore, the generalisation of our 
findings to a clinical disorder such as major depression might be seen problematic. 
However, it has been argued by others that levels of depressive symptoms could be 
of greater relevance for predicting diabetes outcomes than a criteria-based diagnosis 
[e.g. 16,30], and a number of studies support this hypothesis regarding both 
outcomes, self-management behaviour [31] and glycaemic control [32–34]. 
Therefore, the measurement approach chosen here appears not only valid but may 
also improve our understanding of associations between depression and suboptimal 
diabetes outcomes across the range of depressive symptomatology. 
Interestingly, we observed a difference between the type 1 and type 2 diabetes 
groups: The association between depressive symptoms and diabetes self-
management was somewhat larger for type 2 diabetes, accordingly leading to a 
larger mediated association between depressive symptoms and glycaemic control. 
This finding corresponds to the meta-analytic results by Lustman et al. [10], which 
also observed a smaller association between depression and hyperglycaemia in the 
type 1 diabetes group. However, comparing the associations between depressive 
symptoms and self-management across diabetes groups yielded no significant effect, 
thus a systematic difference is not supported. 
Besides self-management behaviour, other potential mechanisms to mediate 
depression-related hyperglycaemia have been discussed. Particularly stress-induced 
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endocrine or inflammatory responses to depressive symptoms may constitute a 
pathway [35], which is supported by findings confirming that comorbid depression in 
diabetes is associated with increased inflammation [36] and in turn with poorer 
glycaemic control [37]. However, the results presented here do not support this 
pathway because the direct associations between depressive symptoms and HbA1c, 
not mediated by behaviour, were non-significant. On the other hand, neither 
biological markers of stress nor psychological stress were assessed in our study 
which limits our claims regarding a direct HPA axis link between stress and 
glycaemic control. Thus, our findings may be best considered as evidence supporting 
the behavioural hypothesis rather than evidence against other putative mechanisms. 
Importantly, recent studies focussing on the relationship between depression and 
glycaemic control found evidence supporting that depression may not generally 
predict hyperglycaemia, but there may be attenuating factors. An aspect of potential 
importance appears to be diabetes-specific distress, as several studies found 
depression associated with hyperglycaemia particularly when diabetes distress was 
present concomitantly [38–40]. These issues require further investigation. 
Nevertheless, the present findings support that the association between depression 
and hyperglycaemia – whether attenuated by diabetes distress or not – is mediated 
by self-management. 
Our results have to be qualified by several limitations of the study: Firstly, the 
data were cross-sectional; hence, the study does not warrant causal inferences. 
Although the findings are in line with the assumption of a causal effect of depression 
leading to impaired diabetes self-management and in turn to hyperglycaemia, 
prospective studies are needed to support causality. Secondly, the sample consisted 
of patients with diabetes enrolled into the study during the stay at an in-patient 
diabetes care centre. People are usually referred there for problems regarding 
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diabetes treatment and control. Additionally, affective symptoms were 
overrepresented. Thus, the sample may not be representative for the primary care 
patient group. Thirdly, the hypothesised mediation was tested for patients with type 1 
and type 2 diabetes separately, leading to reduced sample sizes. Future studies 
should try to replicate our findings on the basis of larger and more representative 
samples. Finally, the performed modelling permitted significant correlations between 
error terms which is regarded as a statistical sleight of hand by some. On the other 
hand, it has been argued that failure to include such correlations may generate 
misleading results [41]. However, since only few correlations between residuals were 
actually observed, it appears unlikely that this aspect may have biased the results. 
The strengths of our study lie in a) the standardised methods (in-patient setting; 
validated psychometric scales; HbA1c analysis in central laboratory; blood sampling 
at the same time as the psychometric assessment; standardised multiple variable 
modelling analysis), warranting high internal validity, and b) the testing of the 
hypotheses on distinct samples of people with type 1 and type 2 diabetes, enabling 
generalisation to both major diabetes types. Furthermore, the revealed mediation 
effects were large enough to reach high significance within study samples of rather 
limited size, which supports the validity of the mediation. Finally, our adjusting for 
potential confounders such as gender, age and education supports the validity of our 
drawn conclusions. 
In sum, our findings support that depression in people with diabetes can be 
associated with hyperglycaemia due to suboptimal diabetes self-management. 
Following this evidence, it is reasonable to assume that the successful treatment of 
comorbid depression may facilitate the provision of optimal diabetes care to this high-
risk patient group (and support of self-care) [4–10], and the established risks of 
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subsequent long-term morbidity based on comorbid depression in diabetes [4–6] 
might be effectively reduced. 
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Table 1. Characteristics of the study samples 
 Type 1 DM 
n = 248 
(57.7%) 
Type 2 DM 
n = 182 
(42.3%) 
P 
value* 
Demographic variables    
Female gender 149 (60.1%) 84 (46.2%) 0.004 
Age (years) 39.0 ± 13.2 57.0 ± 8.9 < 0.001 
BMI (kg/m2) 26.9 ± 11.0 34.1 ± 6.6 < 0.001 
Diabetes-related variables    
Diabetes duration (years) 16.6 ± 12.1 13.5 ± 7.5 0.001 
Diabetes treatment:    
 Insulin treatment 248 (100%) 146 (80.2%) < 0.001 
 Other medical treatment† 0 (0%) 36 (19.8%) < 0.001 
HbA1c    
 Value in % 8.5 ± 1.6 8.6 ± 1.5 0.71 
 Value in mmol/mol 70 ± 18 70 ± 17 0.71 
 Patients with values > 7.5%  
 (60 mmol/mol) 
176 (71.0%) 132 (72.5%) 0.72 
Long-term complications:    
 Retinopathy 57 (23.0%) 43 (23.6%) 0.88 
 Neuropathy 36 (14.5%) 87 (47.8%) < 0.001 
 Nephropathy 11 (4.4%) 33 (18.1%) < 0.001 
 Foot ulcer 5 (2.0%) 18 (9.9%) < 0.001 
CES-D score 22 ± 11 22 ± 10 0.74 
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Data are n (%) or M ± SD. 
BMI, Body Mass Index; HbA1c, glycated haemoglobin; CES-D, Center for 
Epidemiologic Studies Depression Scale; M, mean; SD, standard deviation. 
* testing differences between patients with type 1 versus type 2 diabetes using 
Student‟s t-Test for scaled variables or Pearson‟s χ2-Test for frequencies. 
† oral antidiabetic agents and/or incretin mimetics
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Figure legends 
 
 
Figure 1. Structural equation model of depressive mood, diabetes self-
management and glycaemic control for people with type 1 diabetes (N = 248) 
Data are standardised regression coefficients (β) for paths or squared multiple 
correlations (R2) for variables, adjusted for gender, age, BMI and education. 
Boxes indicate manifest measurement variables; ovals indicate latent variables 
operationalised by manifest indicators; error terms are not displayed for ease of 
presentation. 
SRMR, Standardised Root Mean Square Residual; TLI, Tucker Lewis Index; CFI, 
Comparative Fit Index; RMSEA, Root Mean Square Error of Approximation. 
Indication of two-sided significance: * P < 0.05; † P < 0.01; ‡ P < 0.001; ns not 
significant. 
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Figure 2. Structural equation model of depressive mood, diabetes self-
management and glycaemic control for people with type 2 diabetes (N = 182) 
Data are standardised regression coefficients (β) for paths or squared multiple 
correlations (R2) for variables, adjusted for gender, age, BMI and education. 
Boxes indicate manifest measurement variables; ovals indicate latent variables 
operationalised by manifest indicators; error terms are not displayed for ease of 
presentation. 
SRMR, Standardised Root Mean Square Residual; TLI, Tucker Lewis Index; CFI, 
Comparative Fit Index; RMSEA, Root Mean Square Error of Approximation. 
Indication of two-sided significance: * P < 0.05; † P < 0.01; ‡ P < 0.001; ns not 
significant. 
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Highlights: 
 The study supports a behavioural mediation between depression and 
hyperglycaemia 
 The mediation was observed in both type 1 and type 2 diabetes 
 Depression explained up to 17% of the variation of diabetes self-management 
 Diabetes self-management explained up to 28% of the variation of HbA1c 
 Behavioural mediation effects were of moderate to large size. 
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